KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Assets (2016 - 2025)

Historic Assets for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $133.9 billion.

  • AbbVie's Assets fell 664.05% to $133.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $133.9 billion, marking a year-over-year decrease of 664.05%. This contributed to the annual value of $135.2 billion for FY2024, which is 33.4% up from last year.
  • Latest data reveals that AbbVie reported Assets of $133.9 billion as of Q3 2025, which was down 664.05% from $137.2 billion recorded in Q2 2025.
  • AbbVie's 5-year Assets high stood at $150.5 billion for Q1 2021, and its period low was $133.9 billion during Q3 2025.
  • Its 5-year average for Assets is $140.9 billion, with a median of $141.3 billion in 2022.
  • Per our database at Business Quant, AbbVie's Assets soared by 6502.48% in 2021 and then tumbled by 853.67% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Assets stood at $146.5 billion in 2021, then dropped by 5.27% to $138.8 billion in 2022, then fell by 2.95% to $134.7 billion in 2023, then grew by 0.33% to $135.2 billion in 2024, then dropped by 0.93% to $133.9 billion in 2025.
  • Its Assets was $133.9 billion in Q3 2025, compared to $137.2 billion in Q2 2025 and $136.2 billion in Q1 2025.